Studies directed toward the exploitation of vicinal diols in the synthesis of (+)-nebivolol intermediates

• Runjun Devi and
• Sajal Kumar Das

Beilstein J. Org. Chem. 2017, 13, 571–578, doi:10.3762/bjoc.13.56

• asymmetric synthesis of (R)-1-((R)-6-fluorochroman-2-yl)ethane-1,2-diol, (R)-1-((S)-6-fluorochroman-2-yl)ethane-1,2-diol and (S)-6-fluoro-2-((R)-oxiran-2-yl)chroman, which have been used as late-stage intermediates for the asymmetric synthesis of the antihypertensive drug (S,R,R,R)-nebivolol. Noteworthy is

• chromans have become attractive synthetic targets in academia and pharmaceutical industry [1]. Nebivolol (1, Figure 1) is a chroman-based antihypertensive drug that was first reported in the racemic form [2][3]. Chiral HPLC was subsequently employed to access various stereoisomers of 1 in enantiomerically

• first use of the Sharpless asymmetric dihydroxylation as the sole source of chirality for the synthesis of nebivolol intermediates. The chroman-based antihypertensive drug nebivolol, its biologically active stereoisomers and late-stage intermediates for its synthesis. Synthetic strategies toward late

Efficient and improved synthesis of Telmisartan

• A. Sanjeev Kumar,
• Samir Ghosh and
• G. N. Mehta

Beilstein J. Org. Chem. 2010, 6, No. 25, doi:10.3762/bjoc.6.25

• . This methodology overcomes many of drawbacks associated with previously reported syntheses. Keywords: antihypertensive drug; oxazoline hydrolysis; Suzuki coupling; Telmisartan; Introduction Telmisartan (1) is an angiotensin II receptor antagonist useful in the treatment of hypertension, heart

• diseases, heart attack, and bladder diseases [1][2][3]. Telmisartan is currently available in the market as an antihypertensive drug [4] under the brand name of Micardis®. Essential hypertension is a major risk factor in cardiovascular diseases and is responsible for one-third of global deaths. Most

• antihypertensive drug Telmisartan has been developed, featuring a Suzuki cross-coupling for the construction of the biaryl moiety and a regiospecific reductive amination-condensation sequence for the synthesis of the central benzimidazole. Experimental All solvents and reagents were purchased from the commercial